Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion type Assertion NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_head.
- NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion description "[These findings provide evidence that MCL should be very sensitive to targeted therapy aimed at functional inhibition of the cyclin D1/CDK4 complex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_provenance.
- NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion evidence source_evidence_literature NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_provenance.
- NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion SIO_000772 16690963 NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_provenance.
- NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion wasDerivedFrom befree-2016 NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_provenance.
- NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_assertion wasGeneratedBy ECO_0000203 NP549330.RAQRC9LZGWGKiOPhbVm5c3g84A3Tory3Tp2vsI3QdEfd0130_provenance.